Oral Solid Medications


Full Tech Transfer and localization of oral solid medications which cover mainly the chronic diseases (diabetes, hyperlipidemia, cardiovascular. Etc…).




Opportunity Highlights

  • Expected Investment size of USD 3.5 Billion for the whole segment and not capex / plant- (capex/ plant is 75 Million)
  • Plant capacity: Subjected to review ktpa
  • Expected IRR: - Subjected to review %
  • Payback period: Subjected to review years
  • Job Creation: 588 till 2035 (Source NIS)
  • GDP Impact: Subjected to review %


Download the full Opportunity Here

contact our Oral Solid Medications Expert

Thank you for your interest in the Invest Saudi.

We received your inquiry, and we will get back to you shortly.

Explore Other Sectors